iSpecimen Inc.

ISPC

US45032V1089

Software

Real-time Estimate Cboe BZX Other stock markets 12:32:54 2024-04-19 pm EDT			5-day change	1st Jan Change
0.333 ^USD	-20.90%		+46.87%	-33.40%

Mar. 26	ISpecimen Inc. Announces the Board Changes	CI
Mar. 14	Transcript : ISpecimen Inc., 2023 Earnings Call, Mar 14, 2024

ISpecimen Inc. Appoints Tracy Curley as Chief Executive Officer

January 10, 2023 at 01:11 pm EST

iSpecimen Inc. announced that its Board of Directors has appointed Tracy Curley, former Interim CEO, as CEO, effective immediately. Ms. Curley was previously appointed Interim CEO in September 2022, while concurrently serving as the Company's CFO. With the appointment of Ms. Curley as CEO, the Board will be initiating a comprehensive search process to identify a new CFO.

Latest news about iSpecimen Inc.

ISpecimen Inc. Announces the Board Changes	Mar. 26	CI
Transcript : ISpecimen Inc., 2023 Earnings Call, Mar 14, 2024	Mar. 14
ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
ISpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research	Jan. 23	CI
Ispecimen Inc. Announces Executive Changes	Dec. 21	CI
Transcript : ISpecimen Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Earnings Flash (ISPC) ISPECIMEN Posts Q3 Revenue $2.8M	Nov. 02	MT
ISpecimen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
ISpecimen Inc. Provides Revenue Guidance for Third Quarter 2023	23-10-23	CI
ISpecimen Inc. Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers	23-09-28	CI
Ispecimen Expands Provider Network to Enhance Support for Women's Health Research	23-09-13	CI
ISpecimen to Reduce Headcount by 20% as Part of Restructuring	23-09-06	MT
ISpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers	23-08-16	CI
Transcript : ISpecimen Inc., Q2 2023 Earnings Call, Aug 02, 2023	23-08-02
Earnings Flash (ISPC) ISPECIMEN Posts Q2 Revenue $1.6M, vs. Street Est of $3.1M	23-08-02	MT
ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
ISpecimen Inc. Receives A Letter of Resignation from Christopher Ianelli to Resign as A Director	23-07-07	CI
ISpecimen Inc.Â Adds Thirteen New Biospecimen Suppliers to its Proprietary Marketplace Throughout the First Half of 2023	23-07-06	CI
Earnings Flash (ISPC) ISPECIMEN Reports Q1 Revenue $3M, vs. Street Est of $2.6M	23-05-04	MT
Transcript : ISpecimen Inc., Q1 2023 Earnings Call, May 04, 2023	23-05-04
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Top Premarket Gainers	23-03-22	MT
ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Transcript : ISpecimen Inc., Q4 2022 Earnings Call, Mar 14, 2023	23-03-14
ISpecimen Appoints Eric Langlois as Chief Revenue Officer	23-01-24	CI

Chart iSpecimen Inc.

Duration

Period

More charts

Company Profile

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Companyâs platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

Sector

Software

Calendar

2024-05-06 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for iSpecimen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.421 USD

Average target price

3 USD

Spread / Average Target

+612.59%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
ISPECIMEN INC.	-33.40%	3.93M
MICROSOFT CORPORATION	+6.10%	3,004B
SYNOPSYS INC.	-0.44%	79.28B
CADENCE DESIGN SYSTEMS, INC.	+3.56%	77.94B
DASSAULT SYSTÈMES SE	-13.87%	53.9B
ATLASSIAN CORPORATION	-19.92%	50.22B
PALANTIR TECHNOLOGIES INC.	+19.77%	46.76B
THE TRADE DESK, INC.	+8.45%	39.49B
SEA LIMITED	+36.07%	31.91B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-13.08%	23.99B

Other Software

iSpecimen Inc.

Equities

ISPC

US45032V1089

Software

ISpecimen Inc. Appoints Tracy Curley as Chief Executive Officer

EPS Revisions